Literature DB >> 25933384

Spinal Glia Division Contributes to Conditioning Lesion-Induced Axon Regeneration Into the Injured Spinal Cord: Potential Role of Cyclic AMP-Induced Tissue Inhibitor of Metalloproteinase-1.

Huaqing Liu1, Mila Angert, Tasuku Nishihara, Igor Shubayev, Jennifer Dolkas, Veronica I Shubayev.   

Abstract

Regeneration of sensory neurons after spinal cord injury depends on the function of dividing neuronal-glial antigen 2 (NG2)-expressing cells. We have shown that increases in the number of dividing NG2-positive cells through short-term pharmacologic inhibition of matrix metalloproteinases contributes to recovery after spinal cord injury. A conditioning sciatic nerve crush (SNC) preceding spinal cord injury stimulates central sensory axon regeneration via the intraganglionic action of cyclic adenosine monophosphate. Here, using bromodeoxyuridine, mitomycin (mitosis inhibitor), and cholera toxin B tracer, we demonstrate that SNC-induced division of spinal glia is related to the spinal induction of tissue inhibitor of metalloproteinase-1 and contributes to central sensory axon growth into the damaged spinal cord. Dividing cells were mainly NG2-positive and Iba1-positive and included myeloid NG2-positive populations. The cells dividing in response to SNC mainly matured into oligodendrocytes and microglia within the injured spinal cord. Some postmitotic cells remained NG2-reactive and were associated with regenerating fibers. Moreover, intraganglionic tissue inhibitor of metalloproteinase-1 expression was induced after administration of SNC or cyclic adenosine monophosphate analog (dbcAMP) to dorsal root ganglia in vivo and in primary adult dorsal root ganglia cultures. Collectively, these findings support a novel model whereby a cyclic adenosine monophosphate-activated regeneration program induced in sensory neurons by a conditioning peripheral nerve lesion uses tissue inhibitor of metalloproteinase-1 to protect against short-term proteolysis, enabling glial cell division and promoting axon growth into the damaged CNS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25933384      PMCID: PMC4469649          DOI: 10.1097/NEN.0000000000000192

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  63 in total

1.  Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion.

Authors:  J Bu; N Akhtar; A Nishiyama
Journal:  Glia       Date:  2001-06       Impact factor: 7.452

Review 2.  An alternate perspective on the roles of TIMPs and MMPs in pathology.

Authors:  Craig S Moore; Stephen J Crocker
Journal:  Am J Pathol       Date:  2011-10-25       Impact factor: 4.307

3.  Activated microglia in a rat stroke model express NG2 proteoglycan in peri-infarct tissue through the involvement of TGF-β1.

Authors:  Kana Sugimoto; Ryutaro Nishioka; Airi Ikeda; Ayano Mise; Hisaaki Takahashi; Hajime Yano; Yoshiaki Kumon; Takanori Ohnishi; Junya Tanaka
Journal:  Glia       Date:  2013-12-06       Impact factor: 7.452

4.  Elevated MMP-9 in the lumbar cord early after thoracic spinal cord injury impedes motor relearning in mice.

Authors:  Christopher N Hansen; Lesley C Fisher; Rochelle J Deibert; Lyn B Jakeman; Haoqian Zhang; Linda Noble-Haeusslein; Susan White; D Michele Basso
Journal:  J Neurosci       Date:  2013-08-07       Impact factor: 6.167

5.  Conditioning lesions before or after spinal cord injury recruit broad genetic mechanisms that sustain axonal regeneration: superiority to camp-mediated effects.

Authors:  Armin Blesch; Paul Lu; Shingo Tsukada; Laura Taylor Alto; Kasper Roet; Giovanni Coppola; Dan Geschwind; Mark H Tuszynski
Journal:  Exp Neurol       Date:  2011-12-29       Impact factor: 5.330

6.  Different expression of tissue inhibitor of metalloproteinase family members in rat dorsal root ganglia and their changes after peripheral nerve injury.

Authors:  B Huang; X Zhao; L-B Zheng; L Zhang; B Ni; Y-W Wang
Journal:  Neuroscience       Date:  2011-07-20       Impact factor: 3.590

7.  Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration.

Authors:  Artem Kaplan; Krista J Spiller; Christopher Towne; Kevin C Kanning; Ginn T Choe; Adam Geber; Turgay Akay; Patrick Aebischer; Christopher E Henderson
Journal:  Neuron       Date:  2014-01-22       Impact factor: 17.173

8.  Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve.

Authors:  J P Brockes; K L Fields; M C Raff
Journal:  Brain Res       Date:  1979-04-06       Impact factor: 3.252

9.  Low-density lipoprotein receptor-related protein 1 (LRP1)-dependent cell signaling promotes axonal regeneration.

Authors:  Choya Yoon; Erna A Van Niekerk; Kenneth Henry; Tetsuhiro Ishikawa; Sumihisa Orita; Mark H Tuszynski; W Marie Campana
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

10.  The MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration.

Authors:  Youngsoon Kim; Albert G Remacle; Andrei V Chernov; Huaqing Liu; Igor Shubayev; Calvin Lai; Jennifer Dolkas; Sergey A Shiryaev; Vladislav S Golubkov; Andrew P Mizisin; Alex Y Strongin; Veronica I Shubayev
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

View more
  9 in total

1.  Reciprocal relationship between membrane type 1 matrix metalloproteinase and the algesic peptides of myelin basic protein contributes to chronic neuropathic pain.

Authors:  Sanghyun Hong; Albert G Remacle; Sergei A Shiryaev; Wonjun Choi; Swathi K Hullugundi; Jennifer Dolkas; Mila Angert; Tasuku Nishihara; Tony L Yaksh; Alex Y Strongin; Veronica I Shubayev
Journal:  Brain Behav Immun       Date:  2016-11-07       Impact factor: 7.217

2.  MiR-487b suppressed inflammation and neuronal apoptosis in spinal cord injury by targeted Ifitm3.

Authors:  Dake Tong; Yanyin Zhao; Yang Tang; Jie Ma; Miao Wang; Bo Li; Zhiwei Wang; Cheng Li
Journal:  Metab Brain Dis       Date:  2022-07-08       Impact factor: 3.655

3.  Molecular and cellular identification of the immune response in peripheral ganglia following nerve injury.

Authors:  Jane A Lindborg; Jon P Niemi; Madeline A Howarth; Kevin W Liu; Christian Z Moore; Deepti Mahajan; Richard E Zigmond
Journal:  J Neuroinflammation       Date:  2018-06-26       Impact factor: 8.322

4.  Tissue inhibitors of metalloproteases strike a nerve.

Authors:  Veronica I Shubayev; Alex Y Strongin
Journal:  Neural Regen Res       Date:  2018-11       Impact factor: 6.058

5.  Serum tissue inhibitor of metalloproteinase-1 and risk of cognitive impairment after acute ischaemic stroke.

Authors:  Jinzhuo Ge; Ruyi Li; Pengcheng Yuan; Bizhong Che; Xiaoqing Bu; Hancheng Shao; Tan Xu; Zhong Ju; Jintao Zhang; Yonghong Zhang; Chongke Zhong
Journal:  J Cell Mol Med       Date:  2020-05-20       Impact factor: 5.310

6.  Time-Course Changes of Extracellular Matrix Encoding Genes Expression Level in the Spinal Cord Following Contusion Injury-A Data-Driven Approach.

Authors:  Andrea Bighinati; Zahra Khalajzeyqami; Vito Antonio Baldassarro; Luca Lorenzini; Maura Cescatti; Marzia Moretti; Luciana Giardino; Laura Calzà
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

7.  Sexual Dimorphism of Early Transcriptional Reprogramming in Dorsal Root Ganglia After Peripheral Nerve Injury.

Authors:  Andrei V Chernov; Veronica I Shubayev
Journal:  Front Mol Neurosci       Date:  2021-12-13       Impact factor: 6.261

8.  Sexually dimorphic transcriptional programs of early-phase response in regenerating peripheral nerves.

Authors:  Andrei V Chernov; Veronica I Shubayev
Journal:  Front Mol Neurosci       Date:  2022-08-02       Impact factor: 6.261

9.  Acute- and late-phase matrix metalloproteinase (MMP)-9 activity is comparable in female and male rats after peripheral nerve injury.

Authors:  Albert G Remacle; Swathi K Hullugundi; Jennifer Dolkas; Mila Angert; Andrei V Chernov; Alex Y Strongin; Veronica I Shubayev
Journal:  J Neuroinflammation       Date:  2018-03-20       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.